What question did this study set out to answer?

To synthesize the current and emerging therapeutic approaches for IgA nephropathy (IgAN).

April 21, 2026CureusOpen Access

New Horizons in IgA Nephropathy: Approach to Current and Emerging Therapies

View Full Paper

Ask AI

Bookmark

Authors

This review examines current therapies and emerging options for IgA nephropathy, suggesting a shift to individualized treatment strategies.

To synthesize the current and emerging therapeutic approaches for IgA nephropathy (IgAN).
Reviewed existing literature and clinical trial evidence on therapies for IgAN.
Evaluated various therapeutic options including conservative and targeted treatments.
Current therapies include RAAS inhibitors, SGLT2 inhibitors, and corticosteroids.
Emerging therapies involve endothelin receptor antagonists and immunosuppressive agents.
Evidence suggests a trend towards individualized treatment strategies for better management.

Madhavaram et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

This review examines current therapies and emerging options for IgA nephropathy, suggesting a shift to individualized treatment strategies.